ArticleCureus2025
Prospective Randomised Control Study to Evaluate the Effectiveness of Hypochlorous Acid as a Peritoneal Lavage Agent to Prevent Surgical Site Infection After Exploratory Laparotomy for Perforation Peritonitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Surgical site infections (SSIs) are a major concern following emergency gastrointestinal procedures, particularly exploratory laparotomy for perforation peritonitis, where infection risk is amplified by the inherent contamination of the operative field. Despite prophylactic antibiotics, the microbial burden frequently surpasses host defence thresholds. Intraoperative peritoneal lavage with antimicrobial agents such as hypochlorous acid (HOCl) has emerged as a promising strategy, combining physical removal of contaminants with direct microbicidal action. Methods This was a prospective, randomized controlled trial and 148 patients were included in the study who presented with peritonitis secondary to gastrointestinal perforation. Participants were randomly assigned to receive intraoperative lavage using either HOCl (Group A) or normal saline (Group B). The primary endpoint was the rate of SSIs within 30 days postoperatively. Secondary outcomes included early wound progression, postoperative fever, and rates of wound healing by postoperative days 15 and 30. Additional variables such as patient demographics, comorbidities, surgical parameters, and anatomical factors were evaluated. Results The HOCl group demonstrated a marked reduction in SSI incidence (20.3%) compared to the saline group (39.2%), yielding an absolute risk reduction of 19%. Early postoperative indicators - wound severity escalation and fever by day 3 - were predictive of subsequent SSI. No statistically significant associations were found between infection rates and patient-related or operative variables. By day 15, 79% of patients in the HOCl group showed complete wound healing, significantly outperforming the saline group (50%, p<0.001). All HOCl-treated wounds achieved complete healing by day 30. No adverse reactions or resistant organisms were identified among HOCl intraperitoneal lavage recipients. Conclusion Intraperitoneal hypochlorous acid lavage has a significant role in reducing the rate of SSI in perforation peritonitis cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.